Cencora, Inc.
Health
Performance
5.8
Risk
Sell
Buy
Curious about the Scores? Learn more.

Cencora, Inc. stock rating and score history

All changes in ratings, performance and outlook tracked over time.

05.06.2026
Signs of control returning. Still shaky, but not chaos.
07.05.2026
Losing steam. Solid pieces remain, but cracks are showing.
30.04.2026
Slowing down. Might be a breather – or a shift.
20.08.2025
Climbing out. Risks fading, but not out of the woods.
COR
Low-poly 3D Cencora (COR) stock icon with a stylized medical cross, symbolizing healthcare and biotech.
281.67
+0.07%
5.8
Sell
Buy
Cencora, Inc.

Cencora, Inc. stock price, chart patterns and momentum

Recent price movements, trend behaviour and momentum signals based on real-time market data.

What does Cencora, Inc. do? Business model and key facts

Get the full picture of Cencora, Inc.: what it builds, where it operates, and how it makes money.

Cencora, Inc. Profile

Sector: Healthcare

Industry: Medical - Distribution

Employees (FY): 47000

Cencora, Inc. functions as a global leader in the sourcing and distribution of pharmaceutical products, with operations spanning both the United States and international markets. Within its U.S. Healthcare Solutions segment, the company supplies a broad spectrum of pharmaceutical items, including generic and injectable medications, over-the-counter health products, and home healthcare equipment. Its extensive client network includes acute care hospitals, health systems, a variety of retail and mail-order pharmacies (independent, chain, long-term care), medical clinics, and other healthcare providers. This division also manages the distribution of crucial specialized pharmaceutical products like plasma, blood derivatives, and vaccines. Beyond product supply, Cencora offers comprehensive support services, such as pharmacy management, staffing solutions, and strategic consulting. It develops and implements supply management software, provides packaging services for both institutional and retail healthcare settings, and assists with clinical trial support, post-market approval processes, and commercialization strategies. For biotechnology and pharmaceutical manufacturers, the company delivers data analytics, outcomes research, and other specialized services. Furthermore, Cencora serves the animal health market, providing pharmaceuticals, vaccines, parasiticides, diagnostics, and micro feed ingredients for both companion and production animals. It also offers sales force support to manufacturers and specialized services to medical professionals, particularly oncologists, as well as to hospitals and dialysis clinics. The International Healthcare Solutions division concentrates on global pharmaceutical wholesale activities, associated services, and worldwide commercialization support. It ensures the efficient distribution of medicines, various healthcare goods, and related services to an international customer base comprising pharmacies, doctors, health centers, and hospitals. This segment also delivers specialized transportation and logistics solutions specifically designed for the biopharmaceutical sector. Founded in 1871, the company was formerly known as AmerisourceBergen Corporation before adopting the name Cencora, Inc. in August 2023. Its corporate headquarters are situated in Conshohocken, Pennsylvania.

shop
Company facts
Robert Mauch
CEO
47000
Employees worldwide
shop
Performance
-4.69%
Last 12 months
137.24%
Last 5 years
shop
Growth
$321,33B
Revenue year
$1,57B
Net income
shop
Valuation
$54,80B
Market Cap
38.98
Price/Earnings Ratio

Stocks related to Cencora, Inc.

Selected based on industry alignment and relative market positioning.

MCK
Low-poly 3D McKesson (MCK) stock icon with a stylized delivery box, symbolizing e-commerce and logistics.
784.05
-0.40%
4.0
Sell
Buy
McKesson Corporation
CAH
Cardinal Health, Inc.
223.85
+1.22%
1.7
Sell
Buy
Cardinal Health, Inc.
HSIC
Henry Schein, Inc.
81.25
+1.28%
2.2
Sell
Buy
Henry Schein, Inc.
GRDN
Guardian Pharmacy Services, Inc.
43.09
+0.02%
4.5
Sell
Buy
Guardian Pharmacy Services, Inc.
PBH
Prestige Consumer Healthcare Inc.
47.82
+0.53%
6.6
Sell
Buy
Prestige Consumer Healthcare Inc.

Events and news impacting Cencora, Inc. stock

Earnings, coporate decisions and industry developments that can affect the share price.

Cencora, Inc. fundamentals and technical analysis

Financial fundamentals and technicals signals combined to access stability, momentum and market direction.